
CLINICAL SCIENTIFIC TEAMMichael Ezrokhi, PhD Shuqin Luo, PhD, MD Donna Cowan, CCRC |
Dr. Anthony H. Cincotta President, Chief Science Officer & Founder
Dr. Cincotta is the founder and is responsible for overseeing all research and development. He has over 23 successful years in clinical research, development and is recognized as on of the worlds leading authorities on Metabolic Syndrome and Neuroendrocrine Resetting Therapy.
Richard Scranton, MD Chief Medical Officer
Dr. Scranton earned his MD from Quillen College of Medicine, his MPH from Harvard School of Public Health. Dr. Scranton oversees all Clinical Operations for VeroScience.